No results were found for your search. Please adjust your search term or broaden your search criteria.
Still can't find what you are looking for? We can prepare Custom Research for you.
Atherothrombosis is a type of cardiovascular disease caused by the buildup of plaque in the arteries. This buildup can lead to a variety of complications, including heart attack and stroke. As such, the atherothrombosis drug market is focused on providing treatments to reduce the risk of these complications. These treatments include anticoagulants, antiplatelet agents, and statins. Anticoagulants are used to prevent the formation of blood clots, while antiplatelet agents are used to reduce the risk of clot formation. Statins are used to reduce cholesterol levels, which can help reduce the risk of plaque buildup.
The atherothrombosis drug market is highly competitive, with many companies offering a variety of treatments. Some of the major players in the market include Pfizer, Merck, Sanofi, Bristol-Myers Squibb, and AstraZeneca. Show Less Read more
